What does this mean for you?

You’re not alone 1-4

Over 3 million men are affected by hypogonadism in the United States.

It’s important to treat low testosterone levels as directed by your doctor, which may include monitoring over time5

Treating hypogonadism may lower your chance of long-term health problems.6 Ask your doctor for more details.

You will need to have your testosterone levels checked from time to time and may need to be checked throughout the course of your life7-9

If you are being treated for hypogonadism, you will have blood drawn from time to time to see if your testosterone levels are improving. Levels should be higher than 300 ng/dL.

The Approach to Testosterone Management May Be Long-Term

When it comes to testosterone levels, there are a few things to keep in mind.

  • Hypogonadism is a chronic condition diagnosed by testosterone levels lower than 300 ng/dL and symptoms10
  • Consistent, long-term testosterone replacement therapy (TRT) may help you improve levels and keep them within the normal range (>300 ng/dL)8
  • Not every person will need the same dose of TRT—it depends on how their body responds and what therapy is chosen7-9

If you have questions about your testosterone
levels, contact your doctor to learn about next steps.

References: 1. Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762-769. doi:10.1111/j.1742-1241.2006.00992.x 2. Araujo AB, Esche GR, Kupelian V, et al. Prevalence of Symptomatic Androgen Deficiency in Men. J Clin Endocrinol Metab. 2007;92(11):4241-4247. doi:https://doi.org/10.1210/jc.2007-1245 3. Auerbach JM, Moghalu OI, Das R, et al. Evaluating incidence, prevalence, and treatment trends in adult men with hypogonadism in the United States. Int J Impot Res. Published online November 29, 2021. doi:https://doi.org/10.1038/s41443-021-00471-2 4. United States Demographic Statistics | Infoplease. www.infoplease.com. Published May 16, 2021. https://www.infoplease.com/us/census/demographic-statistics. Accessed August 15, 2023. 5. Al-Sharefi A, Wilkes S, Jayasena CN, Quinton R. How to manage low testosterone level in men: a guide for primary care. Br J Gen Pract. 2020;70(696):364-365. Published 2020 Jun 25. doi:10.3399/bjgp20X710729 6. Yeo S, Holl K, Peñaherrera N, Wissinger U, Anstee K, Wyn R. Burden of Male Hypogonadism and Major Comorbidities, and the Clinical, Economic, and Humanistic Benefits of Testosterone Therapy: A Narrative Review. Clinicoecon Outcomes Res. 2021;13:31-38. Published 2021 Jan 12. doi:10.2147/CEOR.S285434 7. Sizar O, Pico J. Androgen Replacement. PubMed. Published 2022. https://www.ncbi.nlm.nih.gov/books/NBK534853/. Accessed August 15, 2023. 8. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. doi:10.1210/jc.2018-00229 9. Dobs AS, Campbell KJ. An Individualized Approach to Managing Testosterone Therapy in the Primary Care Setting. Int J Gen Med. 2022;15:7719-7733. Published 2022 Oct 7. doi:10.2147/IJGM.S364189. 10. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. Journal of Urology. 2018;200(2):423-432. doi:https://doi.org/10.1016/j.juro.2018.03.115

©2023 Antares Pharma Inc., a Halozyme Company.
All rights reserved. 08/2023  MPACP-128-00005